Pan-immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pan-immunotherapy, covering 2024-07-15 to 2024-07-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer [Phase 2]